Join
Live feed
·
INSIDERFilingvia Quantisnow
Metagenomi Therapeutics Inc. logo

Wein Matthew was granted 10,397 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MGX· Metagenomi Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MGX (Metagenomi Therapeutics Inc.) and more on Quantisnow.